Catalyst Pharmaceutical
CPRX
CPRX
187 hedge funds and large institutions have $583M invested in Catalyst Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 74 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more funds holding
Funds holding: 164 → 187 (+23)
4.92% more ownership
Funds ownership: 64.02% → 68.95% (+4.9%)
24% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 74
Holders
187
Holding in Top 10
3
Calls
$550K
Puts
$454K
Top Buyers
| 1 | +$8.09M | |
| 2 | +$7.73M | |
| 3 | +$7.29M | |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$5.39M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$5.26M |
Top Sellers
| 1 | -$9.95M | |
| 2 | -$3.59M | |
| 3 | -$2.89M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.83M |
| 5 |
RA
Royce & Associates
New York
|
-$2.67M |